|
Clinical data
|
Death
|
Discharge
|
p
|
|---|
|
N = 17
|
N = 66
|
|---|
|
Age (mean, std.)
|
37.6 (9.9)
|
36.2 (9.4)
|
0.590
|
|
Gender (male)
|
11 (64.7)
|
54 (81.8)
|
0.184
|
|
ART
|
12 (70.6)
|
55 (83.3)
|
0.300
|
|
CD4 T < 350 cells/mL
|
14 (82.4)
|
58 (87.9)
|
0.688
|
|
HIV-RNA > 1000 copies
|
14 (82.4)
|
47 (71.2)
|
0.539
|
|
Weight loss
|
14 (82.4)
|
30 (45.5)
|
0.007**
|
|
Very good condition
|
7 (41.2)
|
35 (53.0)
|
0.425
|
|
Lucid and space-oriented
|
8 (47.1)
|
40 (60.6)
|
0.410
|
|
Anemia
|
15 (88.2)
|
43 (65.2)
|
0.079
|
|
Respiratory disorder
|
14 (82.4)
|
42 (63.6)
|
0.244
|
|
Neurological disorder
|
8 (47.1)
|
29 (43.9)
|
0.999
|
|
Cardiovascular disorder
|
2 (11.8)
|
2 (3.0)
|
0.184
|
|
Gastrointestinal disorder
|
8 (47.1)
|
16 (24.2)
|
0.077
|
|
Active coinfections
|
|
Tuberculosis
|
12 (70.6)
|
25 (37.9)
|
0.026*
|
|
Parasites in stools
|
3 (17.6)
|
13 (19.7)
|
0.999
|
|
Toxoplasmosis IgM
|
1 (5.9)
|
7 (10.6)
|
0.999
|
|
Cytomegalovirus IgM
|
1 (5.9)
|
2 (3.0)
|
0.502
|
|
Epstein Barr virus IgM
|
17 (100)
|
66 (100)
|
0.999
|
|
Herpes virus IgM
|
0 (0)
|
3 (4.5)
|
0.999
|
|
Previous infections
|
|
HCV IgG
|
1 (5.9)
|
2 (3.0)
|
0.502
|
|
Cytomegalovirus IgG
|
13 (76.5)
|
53 (80.3)
|
0.741
|
|
Toxoplasmosis IgG
|
13 (76.5)
|
52 (78.8)
|
0.999
|
|
Epstein Barr virus IgG
|
12 (70.6)
|
49 (74.2)
|
0.764
|
|
Herpes virus IgG
|
12 (70.6)
|
44 (66.7)
|
0.999
|
- *, **: p-value; statistically significant difference
